Search Results (42)

Modern lifestyles are increasingly plagued by physical inactivity, social disconnection, digital addiction, and excessive time indoors—factors that negatively impact the health and well-being of both humans and their companion dogs (Canis familiaris). Evidence shows that nature exposure, physical activity, and human–animal bond (HAB) each enhance physical, mental, and social well-being, yet these domains have rarely been examined together as an integrated therapeutic triad. We introduce a new conceptual framework of bonded green exercise, defined as shared physical activity between a bonded human and dog in natural environments. Synthesizing existing evidence across human and canine sciences into a testable conceptual integration, we posit that bonded green exercise may plausibly activate evolutionarily conserved, synergistic mechanisms of physiological, behavioural, and affective co-regulation. Four testable hypotheses are proposed: (H1) triadic synergy: combined domains produce greater benefits than additive effects; (H2) heterospecific benefit: parallel health gains occur in both species; (H3) behavioural amplification: dogs acts as catalysts to drive human participation in nature-based activity; and (H4) scalable health promotion: bonded green exercise represents a low-cost, accessible, One Health approach with population-level potential. This framework highlights how intentional, shared physical activity in nature may potentially offer a novel low-cost and accessible model for enhancing health, lifespan, welfare, and ecological stewardship across species. Full article

Postbiotics, which are preparations of inanimate microorganisms and their components, have emerged as a promising functional ingredient in animal health and nutrition. Postbiotics are primarily composed of microbial cell fractions, metabolites, enzymes, vitamins, polysaccharides, and short-chain fatty acids. Unlike probiotics, postbiotics do not contain live microorganisms, which strengthens their greater stability and safety in feed/food formulations. Postbiotics offer several beneficial effects, including antioxidant, anti-inflammatory, immune-modulatory, and antimicrobial actions. They enhance antioxidant enzymes, neutralize reactive oxygen species, and inhibit lipid peroxidation, thereby protecting tissues from oxidative damage. Postbiotics also inhibit pro-inflammatory molecules like TNF-α and IL-6, while enhancing the anti-inflammatory cytokine IL-10, promoting the maturation and function of immune cells, and increasing secretory IgA production. They suppress a variety of pathogenic bacteria, including Escherichia coli, Salmonella, Staphylococcus, Campylobacter, etc., both in vitro and in vivo. Moreover, they increase beneficial gut bacteria and improve the digestion and integrity of the intestine. This article outlines the beneficial effects of postbiotics in animals including poultry, swine, canine, feline, horses, and ruminant animals, either as feed/food or as a supplement. The integration of postbiotics into animal feed improves growth performance, feed conversion ratios, and disease resistance in animals. Thus, the multifunctional benefits of postbiotics make them a valuable tool for healthy companion animals and sustainable livestock production, supporting both animal welfare and productivity without the drawbacks associated with antibiotic growth promoters. Full article

A significant gap in specific nutritional guidelines for ruminants with compromised health exists. Due to their unique anatomy, physiology, and metabolic processes, further research is needed to establish accurate, evidence-based recommendations tailored to these animals. This review highlights the critical role of clinical ruminant nutrition and provides provisional recommendations based on studies in other species (e.g., changes in nutrient requirements in different morbidities available for humans and less for companion animals). These suggestions should be interpreted cautiously until more definitive, species-specific data become available. The review includes the foundational principles of clinical nutrition in ruminants, with particular emphasis on the pathophysiology of nutrient utilization. It explores the roles of energy, protein, vitamins, and minerals during illness or injury and discusses how these nutrients can be strategically applied in clinical interventions. Considerations for designing diets for compromised ruminants are also addressed, considering both physiological needs and the challenges posed by illness and injury states. Practical aspects of diet delivery during treatment are examined, including the indications, benefits, limitations, and potential side effects of route of feeding. Clinical nutrition can be administered orally, enterally (including rumen delivery) or parenteral, depending on the localization of the pathology and the integrity of the alimentary tract. Nutrients should be provided based on livestock requirements and pathophysiology and severity of the primary morbidity. Oral or ruminal provision of diet should be prioritized to maintain rumen functionality. Additionally, a list of pharmaconutrients with potential clinical applications in ruminant medicine is presented to encourage future research and integration into veterinary practice. The success of clinical nutritional interventions can be measured by improvements in appetite, behavior, and health of the compromised ruminant. Full article

This review examines the diverse ways in which probiotics, defined as live microorganisms that provide health benefits to the host when administered in adequate amounts, contribute to animal health and welfare across both livestock and companion species. By modulating gut microbiota, enhancing immune responses, and suppressing harmful pathogens, probiotics represent an effective strategy for disease prevention and performance improvement without reliance on antibiotics. In livestock production, these beneficial microbes have been shown to optimize feed utilization, support growth, and reduce methane emissions, thereby contributing to more sustainable farming practices. Their role extends beyond productivity, as probiotics also help mitigate antimicrobial resistance (AMR) by offering natural alternatives to conventional treatments. In aquaculture, they further promote environmental sustainability by improving water quality and reducing pathogen loads. For companion animals such as dogs and cats, probiotics are increasingly recognized for their ability to support gastrointestinal balance, alleviate stress through gut–brain axis interactions, and aid in the management of common conditions including diarrhea, food sensitivities, and allergies. The integration of probiotics into veterinary practice thus reflects a growing emphasis on holistic and preventive approaches to animal health. Despite these advances, several challenges remain, including variability in strain-specific efficacy, regulatory limitations, and cost-effectiveness in large-scale applications. Emerging research into precision probiotics, host–microbiome interactions, and innovative delivery methods offers promising avenues to overcome these barriers. As such, probiotics can be regarded not only as functional supplements but also as transformative tools that intersect animal health, productivity, and sustainability. Full article

Increasing interest in functional nutrition has driven the incorporation of probiotics into pet food formulations to enhance digestive health, immune response, and overall well-being in companion animals. This systematic review examines scientific publications, patents, and market developments related to probiotic-enriched pet food from 2014 to 2024. We evaluate major probiotic taxa—including Lactobacillus spp., Bifidobacterium spp., Bacillus spp., and Saccharomyces cerevisiae—based on their resilience during processing, gastrointestinal survival, and documented health benefits. Delivery technologies such as microencapsulation, coating matrices, and post-processing supplementation are analyzed for their effectiveness in preserving probiotic viability within dry and wet food matrices. Patent landscape analysis highlights innovation trends in strain selection, formulation design, and processing methods. In vivo and in vitro studies demonstrate that probiotic supplementation modulates gut microbiota composition, improves fecal parameters, enhances immune markers, and promotes nutrient absorption in both canine and feline models. Market data reveal rapid expansion of commercial probiotic pet food products, yet scientific research remains limited compared to human nutrition. Overall, the findings indicate that while probiotics hold clear potential to improve gastrointestinal health and immunity in pets, evidence remains fragmented, particularly for cats and long-term outcomes. Bridging the gap between industrial innovation and controlled clinical validation will be essential for developing next-generation probiotic pet foods. Full article

Background: Assistance dogs can support children with autism by improving emotional regulation and social functioning, but access is limited. The Family Dog Service was developed to help families of autistic children gain similar benefits through companion dogs. It offers tailored support for selecting, training, and integrating a dog into the home. This study explored parent perspectives on the service and perceived impacts of companion dogs. Methods: A cross-sectional online survey was conducted among UK residents who attended Family Dog Service workshops. The survey included demographic data, mental health and wellbeing measures, and questions about human–animal interactions. Quantitative data were analysed descriptively; qualitative responses underwent thematic analysis. Results: Of 118 participants, 101 (85.6%) owned a dog, while 17 (14.4%) were considering acquisition. Most owners reported improvements in their child’s mood (75.2%; n = 76) and reduced anxiety-related behaviours (70.3%, n = 71) following dog acquisition. Nearly half (49.5%, n = 50) rated the child–dog relationship as ‘very’ or ‘extremely’ positive within the first month, increasing to 86.1% (n = 87) by the time of data collection. Families also reported enhanced dynamics and reduced caregiver stress. Despite some challenges, the service was valued for its autism-specific guidance and ongoing support. Conclusions: The Family Dog Service may offer a practical, accessible alternative to assistance dogs, supporting autistic children’s wellbeing and strengthening family relationships through positive interactions between children and their dogs. Full article

Background/Objectives: Diabetes mellitus (DM) is an increasingly prevalent endocrine disorder affecting humans and companion animals. Type 1 DM (T1DM) and type 2 DM (T2DM) are well characterized in humans, and canine DM most often resembles T1DM, marked by insulin dependence and β-cell destruction. Conversely, feline DM shares key features with human T2DM, including insulin resistance, obesity-related inflammation, and islet amyloidosis. This review provides a comprehensive comparative analysis of antidiabetic therapies in humans, dogs, and cats, focusing on three core areas: disease pathophysiology, pharmacological and delivery strategies, and translational implications. In human medicine, a wide array of insulin analogs, oral hypoglycemic agents, and incretin-based therapies, including glucagon-like peptide-1 receptor agonists (liraglutide) and sodium-glucose cotransporter-2 inhibitors (empagliflozin), are available. Veterinary treatments remain limited to species-adapted insulin formulations and off-label use of human drugs. Interspecies differences in gastrointestinal physiology, drug metabolism, and behavioral compliance influence therapeutic efficacy and pharmacokinetics. Recent innovations, such as microneedle patches for insulin delivery and continuous glucose monitoring systems, show promise in humans and animals. Companion animals with naturally occurring diabetes serve as valuable models for preclinical testing of novel delivery platforms and long-acting formulations under real-world settings. While these technologies show potential, challenges remain in regulatory approval and behavioral adaptation in animals. Conclusions: Future research should prioritize pharmacokinetic bridging studies, veterinary-specific formulation trials, and device validation in animal models. By highlighting shared and species-specific characteristics of DM pathogenesis and treatment, this review advocates a One Health approach toward optimized antidiabetic therapies that benefit human and veterinary medicine. Full article

Background/Objectives: Aging adults are at an increased risk of depression, anxiety, and poor mood. Research indicates that interacting with companion animals may benefit vulnerable older adults’ mental health. Methods: This study randomly assigned 44 medical inpatients (59+ years) to one of three 20 min daily conditions over 3 days: interactions with a dog and handler (AAI: animal-assisted intervention), handler-only control (CC: conversational control), or usual care (UC). Participants were measured at baseline, daily pre/post-intervention, on day 5 post-intervention, and at 1- and 6-month follow-ups. Results: The results show a significant change in trajectory for the AAI group from pre- to post-intervention for anxiety and mood. Study satisfaction was significantly better in the AAI group than in the UC condition. Depression scores did not change significantly. The effects were not sustained from day 1 to day 5 or to either follow-up. Conclusions: The results suggest that short-term interactions with dogs may provide immediate improvements in anxiety and mood, and dog presence adds value above that of the handler alone. Full article

Introduction: Chemotherapy is a primary treatment option in human and veterinary oncology. Like humans, canine patients often develop drug resistance. Comparative oncology is gaining increasing interest, and spontaneous tumors of companion dogs have emerged as a powerful resource for better understanding human cancer. The genetic, molecular, and histological features of tumors in dogs are more closely related to those in humans than the ones in laboratory animals, including complex mechanisms of drug resistance. Methods: A comprehensive literature search was conducted in the electronic database Clarivate Web of Science (WOS): Medical Literature Analysis and Retrieval System Online (MEDLINE) from 1990 to 2025 (updated 22 January 2025). The final set includes 59 relevant full-text English articles. Results: The literature findings suggest that canine spontaneous tumors are valuable model systems with important translational implications for identifying novel mechanisms of chemotherapy resistance shared with humans and may help advance the current standard of care in precision medicine. Conclusions: We have provided an updated overview of the role of canine tumor models to study oncotherapy resistance, focusing on limitations and opportunities for advancement. Despite complementary benefits of such models in translational oncology research, their relevance remains underestimated. Strengthening the collaboration between human and veterinary medicine professionals and comparative medicine researchers, and obtaining the support of interdisciplinary institutions, could contribute to addressing the problem of multidrug resistance for both human and canine patients. Future research may promote using canine spontaneous tumors as translational therapeutic models for human chemoresistance, through a multidisciplinary approach based on the emerging “One Health, One Medicine” paradigm. Full article

Faecal microbiota transplantation (FMT) has emerged as a transformative therapy in human medicine, particularly for managing recurrent Clostridioides difficile infections and other gastrointestinal (GI) disorders. Beyond the GI tract, FMT has shown potential in addressing extraintestinal conditions in people, including metabolic, immune-mediated, dermatological, neurological, and infectious diseases. Research in people has highlighted its efficacy in decolonising multidrug-resistant organisms in infection, mitigating autoimmune diseases, and improving outcomes in metabolic disorders such as obesity and diabetes. Furthermore, FMT has also been linked to enhanced responses to immunotherapy in cancer and improved management of hepatic and renal conditions. These findings underscore the intricate connections between the gut microbiome and systemic health, opening novel therapeutic avenues. In veterinary medicine, while FMT has demonstrated benefits for GI disorders, its application in extraintestinal diseases remains largely unexplored. Emerging evidence suggests that conditions such as atopic dermatitis, chronic kidney disease, immune-mediated diseases, and behavioural disorders in companion animals could benefit from microbiome-targeted therapies. However, significant gaps in knowledge persist, particularly regarding the long-term safety and efficacy for veterinary applications. This review synthesises findings from human medicine to assess their relevance for veterinary applications and future research. Full article

Pet ownership is the most common form of human–animal interaction (HAI), is prevalent worldwide and confers benefits for the health and wellbeing of humans. Here, we examined a large set of anonymised data from the Royal Society for the Prevention of Cruelty to Animals (RSPCA) to identify trends in the intake, adoption and relinquishment of companion animals in England and Wales before and during times of uncertainty, namely, the COVID-19 pandemic and the cost-of-living crisis (COLC). We employed an interrupted time series (ITS) design which controls for pre-existing trends by comparing observed outcomes post-intervention with those expected if the intervention had not occurred. Nearly 200,000 animals were taken in by the RSPCA and over 140,000 animals were adopted or released over the four-year period from 2018 to 2022. When controlling for the brief closure of RSPCA sites, fewer dogs and cats were taken in and adopted during the pandemic compared to pre-pandemic, and the intake and adoption of animals were lower during the COLC than before. A downward trend in the return of animals was observed, and the principal reasons for return were problem behaviours, owner unpreparedness and a change in circumstances. Our ITS analysis also permitted forecast predictions to be made which could prove helpful to the RSPCA. Full article

Dogs are cherished companions, and in today’s world, pets are increasingly regarded as family members. Pet owners are placing growing emphasis on their animals’ health, particularly for dogs. Probiotics, which are living bacteria that benefit the host when given in sufficient quantities, have drawn a lot of interest in the veterinary nutrition community due to their beneficial effects on companion animals, including dogs. This study emphasizes the advantages of adding probiotics to canine diets in order to enhance the health of the gut flora and the technologies used to incorporate probiotics into canine feed. It looks at the best ways to deal with common dog health problems, highlighting probiotics as a helpful substitute for antibiotics, which can have serious adverse effects, encourage bacterial resistance, and disturb the gut’s microbial ecology, which is necessary for digesting. Such disruptions are linked to chronic inflammatory enteropathy and obesity in dogs. This paper also examines biotechnological advancements in probiotic incorporation methods in dog feed, aiming to optimize their health benefits. Probiotic feed supplements may thus represent a promising approach to advancing canine health care, providing a natural adjunct to conventional treatments and preventive measures. Full article

The COVID-19 pandemic has presented significant challenges, including financial strains and mental health issues like depression and loneliness. Human–animal interaction (HAI) offers a potential buffer, as pet ownership has been linked to benefits such as improved psychological well-being, increased perceived social support, and reduced loneliness. Furthermore, attachment to pets appears to moderate these effects, with more attached owners experiencing greater benefits. However, most research has focused on female samples, leaving a gap in understanding HAI among men. This study aimed to examine the relationship between pet attachment and psychological well-being, loneliness, and perceived social support among Greek male pet owners ages 18 to 45. Between January and March 2021, a sample of 87 participants completed a demographics form and four self-reported questionnaires: LAPS for pet attachment, WHO-5 for well-being, a three-item loneliness scale, and MSPSS-Pets for perceived social support. Hierarchical multiple regressions indicated that pet attachment predicted increased perceived social support but showed no significant association with psychological well-being or loneliness. Age emerged as a predictor of well-being, with older men reporting higher levels, but no significant predictors of loneliness were found. These findings suggest that companion animals may provide emotional support but may not alleviate the broader psychological burdens intensified during crises like the pandemic. Full article

Colostrum, the first fluid secreted by the mammary glands of mammalian mothers, contains essential nutrients for the health and survival of newborns. Bovine colostrum (BC) is notable for its high concentrations of bioactive components, such as immunoglobulins and lactoferrin. Despite dogs being the world’s most popular companion animals, there is limited research on their immune systems compared to humans. This summary aims to consolidate published studies that explore the immune benefits of BC, focusing specifically on its implications for dogs. Full article

Companion animals, such as dogs and cats, have gained considerable attention in translational medicine due to their potential as models for human diseases. The use of these animals in research has opened new avenues for developing treatments that can benefit both human and veterinary patients, aligning with the One Health approach. Unlike traditional laboratory models like mice, rats, and rabbits, companion animals naturally develop diseases that closely mirror those in humans, including but not limited to diabetes, aging, cancer, and neurological disorders, making them particularly valuable in translational research. Recent advances have highlighted the role of companion animals in enhancing the effectiveness of novel therapies during clinical trials, as they are exposed to diverse environmental and lifestyle factors similar to those experienced by humans. However, the integration of companion animals into translational medicine presents challenges, particularly in terms of collaboration between veterinary and human medicine, where terminology differences in anatomy, clinical terminology, and animal classification can lead to miscommunication. In conclusion, these findings underscore the need for better implementation of the One Health approach by uniting the fragmented collaboration between veterinarians and doctors through interdisciplinary training and fostering unified efforts across both fields, with experts from various disciplines contributing their specialized knowledge in clinical practice and research. Full article